Document is current

Article History

Received: 9 April 2023

Accepted: 31 May 2023

First Online: 12 July 2023

Declarations

:

: Not applicable.

: Not applicable.

: JL discloses research funding from Fisher & Paykel Healthcare Ltd, Aerogen Ltd, American Association for Respiratory Care (AARC), and Rice Foundation, and speaker fees from AARC, Aerogen Ltd, Heyer Ltd, and Fisher & Paykel Healthcare Ltd. HL discloses research funding from Chang Fung Memorial Foundation. AT discloses research funding from Bayer, and Cardeas. AB discloses research funding from Trudell Medical International, participation in clinical advisory board of Hollo Medical Inc, and participation as science advisor to International Pharmaceutical Aerosol Consortium on Regulation and Science. JR discloses grants or consultancies from ESCMID, European Respiratory Society, Bayer, and Genentech, speaker’s bureau for Norma Hellas. CEL discloses consultancies from Aerogen Ltd, AdvanzPharma, Merck and Pfizer. RD reports personal fees from Astra-Zeneca, Boehringer-Ingelheim, Mylan, UptoDate, and Teva. He is the recipient of research grants form Mylan, Viatris and GSK. AT discloses research funding from Bayer, and Cardeas. LV was employed by DTF Medical from 2001 to 2018 and by Nemera from 2018 to 2020. JBF is Chief Science Officer for Aerogen Pharma Corp 2016 to present and previously Chief Clinical Officer at Aerogen Ltd. SE discloses consultancies from Aerogen Ltd, research support, speaker fees, and travel support from Aerogen Ltd and Fisher & Paykel healthcare. Others do not have any conflict of interest to disclose.